世界のヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射市場インサイト及び予測(250ml、500ml)

◆英語タイトル:Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Insights, Forecast to 2028

QYResearchが発行した調査報告書(QY22JLX10376)◆商品コード:QY22JLX10376
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年7月(※2025年版があります。お問い合わせください。)
◆ページ数:115
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥744,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,117,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,489,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の世界市場のxxx%を占める「250ml」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射のグローバル主要企業には、B.Braun、Fresenius Kabi、Medisan、Otsuka Pharmaceutical、Shandong Qidu Pharma Group、Hangzhou Minsheng、PKU HealthCare Corp., Ltd.、Shandong Hualu Pharmaceutical、CR Double-Crane、Shijiahzhuang No.4 Pharmaceutical、WEGO、CTTQ、Kelun、Sichuan Meida Kangjiale、Huaren Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射市場は、種類と用途によって区分されます。世界のヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
250ml、500ml

【用途別セグメント】
病院、ドラッグストア、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射製品概要
- 種類別市場(250ml、500ml)
- 用途別市場(病院、ドラッグストア、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射販売量予測2017-2028
- 世界のヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射売上予測2017-2028
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の地域別販売量
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射販売量
- 主要メーカー別ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射売上
- 主要メーカー別ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(250ml、500ml)
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の種類別販売量
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の種類別売上
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の種類別価格
・用途別市場規模(病院、ドラッグストア、その他)
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の用途別販売量
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の用途別売上
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の用途別価格
・北米市場
- 北米のヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射市場規模(種類別、用途別)
- 主要国別のヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射市場規模(種類別、用途別)
- 主要国別のヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射市場規模(種類別、用途別)
- 主要国別のヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射市場規模(種類別、用途別)
- 主要国別のヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射市場規模(種類別、用途別)
- 主要国別のヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射市場規模(トルコ、サウジアラビア)
・企業情報
B.Braun、Fresenius Kabi、Medisan、Otsuka Pharmaceutical、Shandong Qidu Pharma Group、Hangzhou Minsheng、PKU HealthCare Corp., Ltd.、Shandong Hualu Pharmaceutical、CR Double-Crane、Shijiahzhuang No.4 Pharmaceutical、WEGO、CTTQ、Kelun、Sichuan Meida Kangjiale、Huaren Pharmaceutical
・産業チェーン及び販売チャネル分析
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の産業チェーン分析
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の原材料
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の生産プロセス
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の販売及びマーケティング
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の産業動向
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射のマーケットドライバー
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の課題
- ヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射の阻害要因
・主な調査結果

Market Analysis and Insights: Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market
Due to the COVID-19 pandemic, the global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 250ml accounting for % of the Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection market size is valued at US$ million in 2021, while the US and Europe Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection include B.Braun, Fresenius Kabi, Medisan, Otsuka Pharmaceutical, Shandong Qidu Pharma Group, Hangzhou Minsheng, PKU HealthCare Corp., Ltd., Shandong Hualu Pharmaceutical and CR Double-Crane, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Scope and Segment
Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection market is segmented by Type and by Sales Channel. Players, stakeholders, and other participants in the global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Sales Channel for the period 2017-2028.
Segment by Type
250ml
500ml
Segment by Sales Channel
Hospitals
Drug Stores
Others
By Company
B.Braun
Fresenius Kabi
Medisan
Otsuka Pharmaceutical
Shandong Qidu Pharma Group
Hangzhou Minsheng
PKU HealthCare Corp., Ltd.
Shandong Hualu Pharmaceutical
CR Double-Crane
Shijiahzhuang No.4 Pharmaceutical
WEGO
CTTQ
Kelun
Sichuan Meida Kangjiale
Huaren Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Product Introduction
1.2 Market by Type
1.2.1 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 250ml
1.2.3 500ml
1.3 Market by Sales Channel
1.3.1 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Size Growth Rate by Sales Channel, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Drug Stores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Region
2.4.1 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Region (2017-2022)
2.4.2 Global Sales Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection by Region (2023-2028)
2.5 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Region
2.5.1 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Region (2017-2022)
2.5.2 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Manufacturers
3.1.1 Global Top Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection in 2021
3.2 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Manufacturers
3.2.1 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue in 2021
3.3 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Type
4.1.1 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Historical Sales by Type (2017-2022)
4.1.2 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Forecasted Sales by Type (2023-2028)
4.1.3 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales Market Share by Type (2017-2028)
4.2 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Type
4.2.1 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Historical Revenue by Type (2017-2022)
4.2.2 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Forecasted Revenue by Type (2023-2028)
4.2.3 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue Market Share by Type (2017-2028)
4.3 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Price by Type
4.3.1 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Price by Type (2017-2022)
4.3.2 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Price Forecast by Type (2023-2028)
5 Market Size by Sales Channel
5.1 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Sales Channel
5.1.1 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Historical Sales by Sales Channel (2017-2022)
5.1.2 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Forecasted Sales by Sales Channel (2023-2028)
5.1.3 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales Market Share by Sales Channel (2017-2028)
5.2 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Sales Channel
5.2.1 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Historical Revenue by Sales Channel (2017-2022)
5.2.2 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Forecasted Revenue by Sales Channel (2023-2028)
5.2.3 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue Market Share by Sales Channel (2017-2028)
5.3 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Price by Sales Channel
5.3.1 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Price by Sales Channel (2017-2022)
5.3.2 Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Price Forecast by Sales Channel (2023-2028)
6 North America
6.1 North America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Size by Type
6.1.1 North America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Type (2017-2028)
6.1.2 North America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Type (2017-2028)
6.2 North America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Size by Sales Channel
6.2.1 North America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Sales Channel (2017-2028)
6.2.2 North America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Sales Channel (2017-2028)
6.3 North America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Size by Country
6.3.1 North America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Country (2017-2028)
6.3.2 North America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Size by Type
7.1.1 Europe Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Type (2017-2028)
7.1.2 Europe Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Type (2017-2028)
7.2 Europe Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Size by Sales Channel
7.2.1 Europe Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Sales Channel (2017-2028)
7.2.2 Europe Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Sales Channel (2017-2028)
7.3 Europe Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Size by Country
7.3.1 Europe Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Country (2017-2028)
7.3.2 Europe Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Size by Type
8.1.1 Asia Pacific Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Type (2017-2028)
8.1.2 Asia Pacific Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Type (2017-2028)
8.2 Asia Pacific Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Size by Sales Channel
8.2.1 Asia Pacific Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Sales Channel (2017-2028)
8.2.2 Asia Pacific Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Sales Channel (2017-2028)
8.3 Asia Pacific Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Size by Region
8.3.1 Asia Pacific Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Size by Type
9.1.1 Latin America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Type (2017-2028)
9.1.2 Latin America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Type (2017-2028)
9.2 Latin America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Size by Sales Channel
9.2.1 Latin America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Sales Channel (2017-2028)
9.2.2 Latin America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Sales Channel (2017-2028)
9.3 Latin America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Size by Country
9.3.1 Latin America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Country (2017-2028)
9.3.2 Latin America Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Size by Type
10.1.1 Middle East and Africa Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Type (2017-2028)
10.1.2 Middle East and Africa Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Type (2017-2028)
10.2 Middle East and Africa Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Size by Sales Channel
10.2.1 Middle East and Africa Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Sales Channel (2017-2028)
10.2.2 Middle East and Africa Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Sales Channel (2017-2028)
10.3 Middle East and Africa Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Size by Country
10.3.1 Middle East and Africa Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 B.Braun
11.1.1 B.Braun Corporation Information
11.1.2 B.Braun Overview
11.1.3 B.Braun Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 B.Braun Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 B.Braun Recent Developments
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Corporation Information
11.2.2 Fresenius Kabi Overview
11.2.3 Fresenius Kabi Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Fresenius Kabi Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Fresenius Kabi Recent Developments
11.3 Medisan
11.3.1 Medisan Corporation Information
11.3.2 Medisan Overview
11.3.3 Medisan Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Medisan Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Medisan Recent Developments
11.4 Otsuka Pharmaceutical
11.4.1 Otsuka Pharmaceutical Corporation Information
11.4.2 Otsuka Pharmaceutical Overview
11.4.3 Otsuka Pharmaceutical Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Otsuka Pharmaceutical Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Otsuka Pharmaceutical Recent Developments
11.5 Shandong Qidu Pharma Group
11.5.1 Shandong Qidu Pharma Group Corporation Information
11.5.2 Shandong Qidu Pharma Group Overview
11.5.3 Shandong Qidu Pharma Group Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Shandong Qidu Pharma Group Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Shandong Qidu Pharma Group Recent Developments
11.6 Hangzhou Minsheng
11.6.1 Hangzhou Minsheng Corporation Information
11.6.2 Hangzhou Minsheng Overview
11.6.3 Hangzhou Minsheng Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Hangzhou Minsheng Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hangzhou Minsheng Recent Developments
11.7 PKU HealthCare Corp., Ltd.
11.7.1 PKU HealthCare Corp., Ltd. Corporation Information
11.7.2 PKU HealthCare Corp., Ltd. Overview
11.7.3 PKU HealthCare Corp., Ltd. Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 PKU HealthCare Corp., Ltd. Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 PKU HealthCare Corp., Ltd. Recent Developments
11.8 Shandong Hualu Pharmaceutical
11.8.1 Shandong Hualu Pharmaceutical Corporation Information
11.8.2 Shandong Hualu Pharmaceutical Overview
11.8.3 Shandong Hualu Pharmaceutical Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Shandong Hualu Pharmaceutical Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Shandong Hualu Pharmaceutical Recent Developments
11.9 CR Double-Crane
11.9.1 CR Double-Crane Corporation Information
11.9.2 CR Double-Crane Overview
11.9.3 CR Double-Crane Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 CR Double-Crane Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 CR Double-Crane Recent Developments
11.10 Shijiahzhuang No.4 Pharmaceutical
11.10.1 Shijiahzhuang No.4 Pharmaceutical Corporation Information
11.10.2 Shijiahzhuang No.4 Pharmaceutical Overview
11.10.3 Shijiahzhuang No.4 Pharmaceutical Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Shijiahzhuang No.4 Pharmaceutical Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Shijiahzhuang No.4 Pharmaceutical Recent Developments
11.11 WEGO
11.11.1 WEGO Corporation Information
11.11.2 WEGO Overview
11.11.3 WEGO Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 WEGO Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 WEGO Recent Developments
11.12 CTTQ
11.12.1 CTTQ Corporation Information
11.12.2 CTTQ Overview
11.12.3 CTTQ Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 CTTQ Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 CTTQ Recent Developments
11.13 Kelun
11.13.1 Kelun Corporation Information
11.13.2 Kelun Overview
11.13.3 Kelun Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Kelun Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Kelun Recent Developments
11.14 Sichuan Meida Kangjiale
11.14.1 Sichuan Meida Kangjiale Corporation Information
11.14.2 Sichuan Meida Kangjiale Overview
11.14.3 Sichuan Meida Kangjiale Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Sichuan Meida Kangjiale Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sichuan Meida Kangjiale Recent Developments
11.15 Huaren Pharmaceutical
11.15.1 Huaren Pharmaceutical Corporation Information
11.15.2 Huaren Pharmaceutical Overview
11.15.3 Huaren Pharmaceutical Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Huaren Pharmaceutical Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Huaren Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Industry Chain Analysis
12.2 Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Production Mode & Process
12.4 Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales and Marketing
12.4.1 Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Sales Channels
12.4.2 Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Distributors
12.5 Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Industry Trends
13.2 Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Drivers
13.3 Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Challenges
13.4 Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Restraints
14 Key Findings in The Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のヒドロキシエチルスターチ130-0.4・塩化ナトリウム注射市場インサイト及び予測(250ml、500ml)(Global Hydroxyethyl Starch 130-0.4 and Sodium Chloride Injection Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。